Would you like to write a trial review or get involved in ISN’s activities to support high-quality studies in kidney care? Contact. The ISN is also pleased to welcome Mohamed Elrggal to the GTF team to expand its social media reach. We look forward to seeing the continued development of global trials under this new leadership. The ISN greatly thanks Brendan and David for their tireless involvement in building on this initiative to expand GTF contributors and increase its circulation. Clinical trials are now highlighted in additional languages: French, Mandarin, Russian, and Spanish.īrendan Smyth is now handing his role as lead coordinator to Michele Provenzano, and Meg Jardine will shortly replace current ISN-ACT chair, David Wheeler. Under Brendan Smyth’s leadership as GTF coordinator, the initiative expanded to provide young nephrologists with the chance to collaborate on each edition. Interest in the GTF is constantly increasing, prompting exchange and discussions on recent developments in kidney health research.
Review focuslist series#
The monthly summary is also discussed during #NephTrials, a series of conversations on Twitter combining expertise from the GTF and ISN-ACT Clinical Trials Toolkit teams, and the #NephJC community. The GTF is promoted and published on the ISN website, the ISN Academy, the ISN Insight newsletter, and ISN social media channels.
The I SN-ACT Global Trials Focus (GTF) is a monthly list identifying and summarizing recent interesting trials relevant to kidney disease. Complement-Mediated Kidney Diseases Toolkit.Hydration For Kidney Health Research Initiative.The Professor Donal O’Donoghue, Global Kidney Policy Forum.United Nations (UN): Economic and Social Council (ECOSOC).This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. NASDAQ data is at least 15 minutes delayed. NYSE and AMEX data is at least 20 minutes delayed. Visit to get our data and content for your mobile app or website. Visit Performance Disclosure for information about the performance numbers displayed above. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Focus lists generally consist of a small number of stocks that the firm believes are the most. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Focus List: A list of recommended stocks published by an investment firm's research department. The monthly returns are then compounded to arrive at the annual return. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
Review focuslist plus#
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. These returns cover a period from Januthrough July 4, 2022. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. and Morningstar, Inc.Ĭopyright 2022 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606Īt the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Forbes Media, LLC Investor's Business Daily, Inc. Each of the company logos represented herein are trademarks of Microsoft Corporation Dow Jones & Company Nasdaq, Inc. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein.
0 kommentar(er)
